FDA Clearance Tracker · P140032
Implantable System for Remodulin
Last checked: Nov 19, 2026Latest source record: Dec 22, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2017
Approval withdrawn
Time to decision
1,095 days
Received Dec 23, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P140032
- Device name
- Implantable System for Remodulin
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Dec 23, 2014
- Decided
- Dec 22, 2017
- Decision
- Approval withdrawn
- Supplements
- 72 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
Approval for the Implantable System for Remodulin®. This device is indicated for adult patients with Class I, II and III pulmonary arterial hypertension (PAH) receiving intravenous delivery of Remodulin.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LKK. The earliest in FDA's data is P800036, decided Mar 3, 1982.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.